首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1606553

全球脈搏血氧計市場 - 2024-2031

Global Pulse Oximeter Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球脈搏血氧計市場規模達31.1億美元，預計2031年將達到56.8億美元，2024-2031年預測期間複合年成長率為7.9%。

脈搏血氧儀是一種非侵入性醫療設備，用於測量個別血液中的氧飽和度 (SpO2)。它通常連接在指尖上，透過使用光波長來評估血液中存在的氧合血紅蛋白與脫氧血紅蛋白的比率。脈搏血氧測定法在臨床環境中的日益廣泛使用已使其成為一種標準做法，通常被稱為“第五生命徵象”，與心率、血壓、呼吸頻率和體溫等傳統生命徵象並列。

脈搏血氧儀的主要用途是提供即時、精確的血氧飽和度讀數。對於健康個體，正常 SpO2 水平通常在 95% 到 100% 之間。讀數低於此閾值可能表示潛在的健康問題，例如低氧血症，即血液中氧氣不足。

脈搏血氧儀能夠快速檢測氧氣水平的微小波動，使其成為緊急和重症監護環境中的重要工具。它們經常用於監測患有慢性阻塞性肺病、氣喘和肺炎等呼吸系統疾病的患者，或在需要鎮靜的外科手術過程中進行監測。這些因素推動了全球脈搏血氧計市場的擴張。

市場動態：

驅動程式和限制

脈搏血氧計的技術進步

脈搏血氧計的技術進步極大地推動了全球脈搏血氧計市場的成長，預計這種成長將在整個市場預測期內持續下去。這些創新提高了脈搏血氧計的功能、準確性和方便用戶使用性，使其對醫療保健提供者和患者越來越有吸引力。

現代脈搏血氧儀採用了複雜的演算法和訊號處理技術，可顯著提高血氧飽和度 (SpO2) 讀數的準確性。 Masimo 的訊號擷取技術 (SET) 等創新技術使設備即使在低血流量或病患移動等困難條件下也能提供可靠的測量。這種可靠性水準在臨床環境中至關重要，精確監測對於病患安全至關重要。

ScienceDiect 研究出版物指出，脈搏血氧測定法是一種非侵入性光學方法，用於連續評估動脈血氧飽和度 (SpO2)。它被廣泛認為是近年來患者監測領域最重要的進步之一。由於其操作簡單、成本降低以及快速檢測低氧血症的能力，脈搏血氧測定法已成為麻醉期間以及全球復健室和重症監護病房監測氧飽和度的標準。

穿戴式健康技術的發展催生了可連續佩戴的脈搏血氧計，從而能夠即時監測生命徵象。具有脈搏血氧測定功能的智慧手錶等設備有助於持續的健康追蹤，這對於管理慢性病和促進患者參與健康管理特別有益。

此外，關鍵參與者的策略（例如夥伴關係和協作）將推動脈搏血氧計市場的成長。例如，2023 年 1 月，飛利浦和 Masimo 宣布擴大合作夥伴關係，重點透過將 Masimo 新推出的 W1 智慧手錶整合到飛利浦的企業患者監護生態系統中來增強遠距患者監護能力。此次合作旨在改善遠距醫療應用，從而能夠在家庭環境中對患者進行持續健康監測。所有這些因素都對全球脈搏血氧儀市場提出了需求。

此外，對與遠距醫療解決方案整合的需求不斷成長，有助於全球脈搏血氧儀市場的擴張。

產品召回

產品召回將阻礙全球脈搏血氧儀市場的成長。脈搏血氧儀市場的產品召回凸顯了重大的安全問題，可能會對消費者信任和整體市場動態產生不利影響。一個值得注意的例子是 GE HealthCare 召回了超過 81,000 個 TruSignal 脈搏血氧飽和度感測器，這凸顯了與故障設備相關的潛在危險。此次召回被 FDA 列為 I 類事件，顯示這些設備可能對患者構成嚴重風險，包括可能導致醫療狀況惡化甚至死亡。

此次召回是在發現某些 TruSignal 感測器可能故障後啟動的，特別是在除顫等危急情況下。此類故障可能會妨礙除顫器向患者心臟輸送必要能量的能力，這可能會在危及生命的緊急情況下阻礙基本治療。

同樣，2024 年 4 月，全球基金品質保證和合規團隊收到了有關 Masimo Corporation 對某些 Rad-G 脈搏血氧計設備發起召回的緊急訊息。此次召回是由一項調查發現的一個重大問題引發的，其中一些設備可能會無意中改變其電源狀態，這意味著它們可能會在用戶不按下電源按鈕的情況下關閉或打開。

Rad-G 脈搏血氧儀的問題在於它們意外關閉，這可能導致監測功能喪失。這種情況帶來了嚴重的風險，特別是在臨床環境中，持續監測患者對於及時進行醫療干預至關重要。因此，上述因素可能限制全球脈搏血氧儀市場的潛在成長。

有關此報告的更多詳細資訊 - 索取樣本

A pulse oximeter is a noninvasive medical device used to measure the oxygen saturation level (SpO2) in an individual's blood. Typically attached to a fingertip, it operates by employing light wavelengths to assess the ratio of oxygenated hemoglobin to deoxygenated hemoglobin present in the bloodstream. The growing use of pulse oximetry in clinical settings has established it as a standard practice, often referred to as the "fifth vital sign," alongside traditional vital signs such as heart rate, blood pressure, respiratory rate, and temperature.

The main purpose of a pulse oximeter is to deliver immediate and precise readings of blood oxygen saturation levels. For healthy individuals, normal SpO2 levels generally range from 95% to 100%. Readings falling below this threshold may indicate potential health concerns, such as hypoxemia, where there is inadequate oxygen in the blood.

Pulse oximeters are capable of quickly detecting even minor fluctuations in oxygen levels, making them essential tools in emergency and critical care environments. They are frequently employed to monitor patients with respiratory conditions such as COPD, asthma, and pneumonia or during surgical procedures requiring sedation. These factors have driven the global pulse oximeter market expansion.

Market Dynamics: Drivers & Restraints

Technological Advancements in Pulse Oximeters

Technological advancements in pulse oximeters are significantly driving the global pulse oximeter market's growth, which is expected to continue throughout the market forecast period. These innovations improve the functionality, accuracy, and user-friendliness of pulse oximeters, making them increasingly attractive to both healthcare providers and patients.

Modern pulse oximeters incorporate sophisticated algorithms and signal processing technologies that significantly enhance the accuracy of oxygen saturation (SpO2) readings. Innovations such as Masimo's Signal Extraction Technology (SET) allow devices to deliver reliable measurements even under difficult conditions, such as low blood flow or patient movement. This level of reliability is vital in clinical settings where precise monitoring is essential for patient safety.

As ScienceDitect research publication stated pulse oximetry is a noninvasive optical method used for the continuous evaluation of arterial oxygen saturation (SpO2). It is widely considered one of the most significant advancements in patient monitoring in recent years. Driven by its operational simplicity, decreasing costs, and the ability to swiftly detect hypoxemia, pulse oximetry has become the standard for monitoring oxygen saturation during anesthesia, as well as in recovery rooms and intensive care units globally.

The growth of wearable health technology has led to the creation of pulse oximeters that can be worn continuously, enabling real-time monitoring of vital signs. Devices like smartwatches that include pulse oximetry functions facilitate ongoing health tracking, which is especially beneficial for managing chronic conditions and promoting patient engagement in their health management.

Furthermore, key player's strategies such as partnerships and collaborations would drive this pulse oximeter market growth. For instance, in January 2023, Philips and Masimo announced an expansion of their partnership, focusing on enhancing remote patient monitoring capabilities through the integration of Masimo's newly launched W1 smartwatch into Philips' enterprise patient monitoring ecosystem. This collaboration aims to improve telehealth applications, allowing for continuous health monitoring of patients in home settings. All these factors demand the global pulse oximeter market.

Moreover, the rising demand for integration with telehealth solutions contributes to the global pulse oximeter market expansion.

Product Recalls

The product recalls will hinder the growth of the global pulse oximeter market. Product recalls in the pulse oximeter market underscore significant safety concerns that can adversely affect consumer trust and overall market dynamics. A notable instance is the GE HealthCare recall of over 81,000 TruSignal pulse oximetry sensors, which highlights the potential dangers associated with faulty devices. This recall was classified as a Class I event by the FDA, indicating that these devices could pose serious risks to patients, including the possibility of worsening medical conditions or even death.

The recall was initiated after it was discovered that some TruSignal sensors might malfunction, particularly during critical situations such as defibrillation. Such malfunctions could hinder the defibrillator's ability to deliver necessary energy to a patient's heart, potentially obstructing essential therapy during life-threatening emergencies.

Similarly, in April 2024, the Global Fund Quality Assurance and Compliance Team received urgent information regarding a recall initiated by Masimo Corporation for certain Rad-G Pulse Oximeter devices. The recall was prompted by an investigation that identified a significant issue some of these devices could unintentionally change their power state, meaning they might turn off or on without the user pressing the power button.

The problem with the Rad-G pulse oximeters involves them powering off unexpectedly, which can lead to a loss of monitoring capabilities. This situation poses serious risks, especially in clinical settings where continuous monitoring of patients is critical for timely medical intervention. Thus, the above factors could be limiting the global pulse oximeter market's potential growth.

For more details on this report - Request for Sample

Segment Analysis

The global pulse oximeter market is segmented based on Product Type, technology, component, age group, end-user, and region.

Product Type:

The portable pulse oximeter segment is expected to dominate the global pulse oximeter market share

The portable pulse oximeter segment currently holds a significant portion of the global pulse oximeter market and is expected to continue holding a significant portion during the forecast period.

This segment encompasses devices that are compact, user-friendly, and suitable for continuous monitoring of oxygen saturation levels across various environments, including hospitals, home care, and long-term care facilities. It is fueled by several key factors that enhance its appeal to both healthcare providers and consumers.

Portable pulse oximeters are designed for ease of use and portability, making them ideal for patients who need to monitor their oxygen levels outside clinical settings. Their compact design facilitates easy transport, allowing patients to track their health at home or while traveling. There are 3 types of portable pulse oximeters fingertip pulse oximeter, handheld pulse oximeter, and wearable pulse oximeter.

The growing trend towards home healthcare has significantly boosted the demand for portable pulse oximeters. As more individuals manage chronic conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma at home, the need for reliable monitoring devices has become crucial. Portable pulse oximeters offer a practical solution for self-monitoring oxygen saturation levels.

Furthermore, key player strategies such as partnerships and collaborations would drive this segment's growth in the pulse oximeter market. For instance, in November 2023, GE HealthCare and Masimo announced a collaboration to integrate Masimo SET Pulse Oximetry into GE HealthCare's Portrait Mobile platform, a wireless and wearable patient monitoring solution. This partnership aims to enhance patient monitoring capabilities, particularly in mobile settings, by leveraging Masimo's advanced pulse oximetry technology. These factors have solidified the segment's position in the global pulse oximeter market.

Geographical Analysis

North America is expected to hold a significant position in the global pulse oximeter market share

North America holds a substantial position in the global pulse oximeter market and is expected to hold most of the market share.

The region has a high incidence of chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. This prevalence drives the demand for effective monitoring solutions like pulse oximeters, which are essential for managing these conditions.

According to the Centers for Disease Control and Prevention (CDC) data in 2021, over 15 million Americans (approximately 6.4%) reported being diagnosed with Chronic Obstructive Pulmonary Disease (COPD). This condition is associated with several major risk factors, including tobacco smoking, occupational and environmental exposures, respiratory infections, and genetic predispositions. The prevalence of COPD can be assessed both in crude terms and through age-adjusted statistics, reflecting its significant impact on public health in the U.S. All these factors demand the global pulse oximeter market.

Furthermore, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, product launches & approvals, and collaborations & partnerships would propel the pulse oximeter market growth. For instance, in February 2024, Masimo Corporation announced the FDA clearance of its MightySat Medical, marking it as the first and only FDA-cleared medical fingertip pulse oximeter available for purchase over-the-counter (OTC) without a prescription. The FDA granted 510(k) clearance to MightySat Medical after determining that it is substantially equivalent to a previously cleared prescription device from Masimo.

Also, in March 2024, Movano Health completed a hypoxia trial in collaboration with the University of California, San Francisco (UCSF), which yielded promising results regarding the accuracy of its Evie Ring pulse oximeter. This trial confirmed that the Evie Ring's blood oxygen saturation (SpO2) measurements exceed the accuracy guidelines set by the U.S. Food and Drug Administration (FDA).

Similarly, in May 2024, Masimo announced the FDA clearance for its new baby monitoring system called Stork, designed specifically for healthy infants aged 0 to 18 months. This innovative device allows parents and caregivers to monitor key vital signs without the need for a prescription, making it accessible for home use. Thus, the above factors are consolidating the region's position as a dominant force in the global pulse oximeter market.

Asia Pacific is growing at the fastest pace in the global pulse oximeter market share

Asia Pacific holds the fastest pace in the global pulse oximeter market and is expected to hold most of the market share.

The rise in respiratory conditions, particularly chronic obstructive pulmonary disease (COPD) and asthma, significantly boosts the demand for pulse oximeters. These devices are crucial for monitoring blood oxygen levels and essential for managing respiratory health effectively. The World Health Organization has reported that COPD is a leading cause of death globally, with a substantial burden falling on low- and middle-income countries where the need for monitoring tools is critical.

The Asian Development Bank's report, data in November 2022, "Strengthening Oxygen Systems in Asia and the Pacific," emphasizes the vital importance of pulse oximeters in pneumonia treatment, especially for children. It highlights that effective oxygen therapy and monitoring are crucial for managing pneumonia, which remains a leading cause of illness and death among young children.

A meta-analysis of oxygen improvement programs referenced in the report shows significant advantages linked to the use of pulse oximetry in pneumonia treatment. Notably, it indicates a 48% decrease in hospital mortality rates from pneumonia in children under five years old. This statistic underscores how timely and precise monitoring of oxygen levels can greatly enhance survival rates for this vulnerable age group.

Countries like China and India are experiencing rapid population growth alongside an aging demographic that is more vulnerable to chronic diseases. This demographic shift increases the demand for medical devices such as pulse oximeters, which facilitate ongoing health monitoring in both hospital and home care settings.

Furthermore, key players in the industry product launches that would drive this global pulse oximeter market growth. For instance, in February 2023, Heal Force introduced the FS-E2 Pulse Oximeter, a new product designed to effectively meet the blood oxygen saturation detection needs of residents, particularly elderly patients. This device is capable of real-time monitoring of blood oxygen saturation and pulse rate, allowing for timely detection of silent hypoxic symptoms in older adults in China.

Also, in October 2022, Max Ventilator is poised to introduce a range of new medical devices, including a pulse oximeter, ECG monitors, and other patient monitoring solutions. This initiative reflects the company's recognition of the growing demand for smart and innovative devices in the healthcare sector, aiming to enhance patient care and monitoring capabilities in India. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global pulse oximeter market.

Competitive Landscape

The major global players in the pulse oximeter market include Masimo., Medtronic plc, Koninklijke Philips N.V., Nonin., NIHON KOHDEN CORPORATION., GE Healthcare, CONTEC MEDICAL SYSTEMS CO., LTD, ChoiceMMed, Dragerwerk AG & Co. KGaA, and ICU Medical, Inc. among others.

Key Developments

In August 2024, Prevounce Health launched its first blood oxygen device for remote patient monitoring (RPM), named the Pylo OX1-LTE. This new pulse oximeter is designed to enhance the management of patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) and asthma, as well as other health scenarios that require continuous monitoring, and treatments that necessitate heart rate tracking.
In May 2024, Masimo announced a partnership with Medable Inc. to integrate its medical-grade wearable devices into clinical research. This collaboration involves the incorporation of Masimo's MightySat Rx pulse oximeter into Medable's evidence-generation platform for eight large-scale pharmaceutical clinical trials focused on two oncology indications breast cancer and lung cancer.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global pulse oximeter market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Component
3.4. Snippet by Age Group
3.5. Snippet by End-User
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements in Pulse Oximeters
- 4.1.2. Restraints
  - 4.1.2.1. Product Recalls
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Portable Pulse Oximeter*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Fingertip Pulse Oximeter
- 6.2.4. Handheld Pulse Oximeter
- 6.2.5. Wearable Pulse Oximeter
6.3. Tabletop/Bedside Pulse Oximeter

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Conventional Devices*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Connected Devices

8. By Component

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 8.1.2. Market Attractiveness Index, By Component
8.2. Monitors*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sensors

9. By Age Group

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 9.1.2. Market Attractiveness Index, By Age Group
9.2. Adults*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Pediatrics

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Homecare Settings
10.4. Ambulatory Surgical Centers
10.5. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.8.1. U.S.
  - 11.2.8.2. Canada
  - 11.2.8.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.8.1. Germany
  - 11.3.8.2. U.K.
  - 11.3.8.3. France
  - 11.3.8.4. Spain
  - 11.3.8.5. Italy
  - 11.3.8.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.8.1. Brazil
  - 11.4.8.2. Argentina
  - 11.4.8.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.8.1. China
  - 11.5.8.2. India
  - 11.5.8.3. Japan
  - 11.5.8.4. South Korea
  - 11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Masimo.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Medtronic plc
13.3. Koninklijke Philips N.V.
13.4. Nonin.
13.5. NIHON KOHDEN CORPORATION.
13.6. GE Healthcare
13.7. CONTEC MEDICAL SYSTEMS CO., LTD
13.8. ChoiceMMed
13.9. Dragerwerk AG & Co. KGaA
13.10. ICU Medical, Inc.

LIST NOT EXHAUSTIVE